Kitajima Kazuhiro, Doi Hiroshi, Kuribayashi Kozo
Division of Nuclear Medicine and PET Center, Department of Radiology, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo, 663-8501, Japan.
Department of Radiology, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo, 663-8501, Japan.
Jpn J Radiol. 2016 Aug;34(8):537-47. doi: 10.1007/s11604-016-0555-1. Epub 2016 May 24.
Positron emission tomography/computed tomography (PET/CT) integrated with 2-[(18)F]fluoro-2-deoxy-D-glucose ((18)F-FDG) has emerged as a powerful tool for combined metabolic and anatomic evaluations in clinical oncologic imaging. This review discusses the utility of (18)F-FDG PET/CT as a tool to manage patients with malignant pleural mesothelioma. We discuss different stages of patient management in malignant pleural mesothelioma, including diagnosis, initial staging, therapy planning, early treatment response assessment, re-staging, and prognosis.
正电子发射断层扫描/计算机断层扫描（PET/CT）与2-[(18)F]氟-2-脱氧-D-葡萄糖（(18)F-FDG）相结合，已成为临床肿瘤成像中进行代谢和解剖联合评估的强大工具。本综述讨论了(18)F-FDG PET/CT作为管理恶性胸膜间皮瘤患者工具的效用。我们讨论了恶性胸膜间皮瘤患者管理的不同阶段，包括诊断、初始分期、治疗计划、早期治疗反应评估、重新分期和预后。
